Literature DB >> 8244458

Pentoxifylline: a potent inhibitor of IL-2 and IFN-gamma biosynthesis and BCG-induced cytotoxicity.

A Thanhäuser1, N Reiling, A Böhle, K M Toellner, M Duchrow, D Scheel, C Schlüter, M Ernst, H D Flad, A J Ulmer.   

Abstract

In the present study we investigated the influence of pentoxifylline (POF) on bacillus Calmette-Guérin (BCG)- and phytohaemagglutinin (PHA)-induced DNA synthesis and cytokine release, and BCG-induced cytotoxicity of human peripheral blood mononuclear cells (PBMC). DNA synthesis of PBMC stimulated with either BCG or PHA was inhibited by POF. We also demonstrated that the addition of POF led to a POF dose-dependent decrease of the release of the cytokines interleukin (IL)-2, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha). The release of IL-6 remained unaffected. With respect to the inhibition of BCG-induced IL-2 and IFN-gamma release POF is active at the transcriptional (mRNA) level, as found by polymerase chain reaction (PCR). However, PHA-induced mRNA expression of these lymphokines is not affected by POF. Thus, the existence of a post-transcriptional regulation of PHA-induced cytokine release by POF can be assumed. The observed inhibition of cytokine release is correlated with a potent inhibitory effect of POF on BCG-induced cytotoxicity against bladder tumour cell lines. This effect is reversible.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8244458      PMCID: PMC1422099     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Density-dependent tumor cell death and reversible cell cycle arrest: mutually exclusive modes of monocyte-mediated growth control.

Authors:  J van der Bosch; S Rüller; D Horn; R Schumann; M Schlaak
Journal:  Exp Cell Res       Date:  1990-04       Impact factor: 3.905

Review 2.  Interleukin-4. A regulatory protein.

Authors:  J H Jansen; W E Fibbe; R Willemze; J C Kluin-Nelemans
Journal:  Blut       Date:  1990-05

3.  Purification of mRNA directly from crude plant tissues in 15 minutes using magnetic oligo dT microspheres.

Authors:  K S Jakobsen; E Breivold; E Hornes
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

4.  75Se-release: a short and long term assay system for cellular cytoxicity.

Authors:  W Leibold; S Bridge
Journal:  Z Immunitatsforsch Immunobiol       Date:  1979-03

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

7.  Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines.

Authors:  M H Wang; H D Flad; A Böhle; Y Q Chen; A J Ulmer
Journal:  Immunol Lett       Date:  1991-03       Impact factor: 3.685

8.  Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone.

Authors:  C C Chao; S Hu; K Close; C S Choi; T W Molitor; W J Novick; P K Peterson
Journal:  J Infect Dis       Date:  1992-10       Impact factor: 5.226

9.  Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro.

Authors:  A Thanhäuser; A Böhle; H D Flad; M Ernst; T Mattern; A J Ulmer
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

10.  Evidence that pentoxifylline reduces anti-CD3 monoclonal antibody-induced cytokine release syndrome.

Authors:  M L Alegre; K Gastaldello; D Abramowicz; P Kinnaert; P Vereerstraeten; L De Pauw; P Vandenabeele; M Moser; O Leo; M Goldman
Journal:  Transplantation       Date:  1991-10       Impact factor: 4.939

View more
  16 in total

1.  Inhibition of human interleukin-12 production by pentoxifylline.

Authors:  D R Moller; M Wysocka; B M Greenlee; X Ma; L Wahl; G Trinchieri; C L Karp
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

2.  Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.

Authors:  J Fleischer; E Soeth; N Reiling; E Grage-Griebenow; H D Flad; M Ernst
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

3.  In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.

Authors:  J M Reimund; S Dumont; C D Muller; J S Kenney; M Kedinger; R Baumann; P Poindron; B Duclos
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

4.  Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections.

Authors:  S Haraguchi; R A Good; M James-Yarish; G J Cianciolo; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

5.  Different regulatory effects of pentoxifylline on human T cell activation pathways.

Authors:  R P Dong; Y Umezawa; H Ikushima; Y Munakata; S F Schlossman; C Morimoto
Journal:  J Clin Immunol       Date:  1997-05       Impact factor: 8.317

6.  Steroid-sparing effects of pentoxifylline in pulmonary sarcoidosis.

Authors:  M K Park; H Babaali; L I Gilbert-McClain; M Stylianou; J Joo; J Moss; V C Manganiello
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2009-07       Impact factor: 0.670

7.  Pentoxifylline inhibits the synthesis and IFN-gamma-inducing activity of IL-18.

Authors:  T Samardzic; V Jankovic; S Stosic-Grujicic; D Popadic; V Trajkovic
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

8.  Isotype-specific regulation of MHC class II gene expression in human monocytes by exogenous and endogenous tumor necrosis factor.

Authors:  M Jasiński; J Wieckiewicz; I Ruggiero; A Pituch-Noworolska; M Zembala
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

9.  Immunomodulating properties of the antibiotic novobiocin in human monocytes.

Authors:  A Lührmann; J Thölke; I Behn; J Schumann; G Tiegs; S Hauschildt
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

10.  Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative.

Authors:  X H Gan; J P Robin; J M Huerta; P Braquet; B Bonavida
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.